Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dietmar Seiffert

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Biochemical and Biophysical Research Communications|December 3, 2002
Mutations at the P1' position of Notch1 decrease intracellular domain stability rather than cleavage by gamma-secretaseYuval Blat, Jere E Meredith, Qian Wang, et al.
European Journal of Pharmacology|April 11, 2015
Platelet transfusion reverses bleeding evoked by triple anti-platelet therapy including vorapaxar, a novel platelet thrombin receptor antagonistTian-Quan Cai, L Alexandra Wickham, Gary Sitko, et al.
Thrombosis and Haemostasis|March 8, 2003
CD32-dependent platelet activation by a drug-dependent antibody to glycoprotein IIb/IIIa antagonistsDonna L Pedicord, Ira Dicker, Karyn O'Neil, et al.
Thrombosis and Haemostasis|March 28, 2002
Plasminogen has a broad extrahepatic distributionLu Zhang, Dietmar Seiffert, Bruce J Fowler, et al.
The Journal of Biological Chemistry|January 5, 2002
Identification and characterization of presenilin-independent Notch signalingBridget E Berechid, Magali Kitzmann, Daniel R Foltz, et al.
European Journal of Heart Failure|June 7, 2019
Rationale and design for the development of a novel nitroxyl donor in patients with acute heart failureG Michael Felker, Maria Borentain, John G Cleland, et al.
Pharmacology Research & Perspectives|March 16, 2016
Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic targetWendy Ankrom, Harold B Wood, Jiayi Xu, et al.
Frontiers in Molecular Biosciences|June 26, 2023
Identification and validation of G protein-coupled receptors modulating flow-dependent signaling pathways in vascular endothelial cellsDike Qiu, Ke Xu, Namjin Chung, et al.
Platelets|July 10, 2003
Effects of the glycoprotein IIb/IIIa antagonist Roxifiban on P-selectin expression, fibrinogen binding, and microaggregate formation in a phase I dose-finding study: no evidence for platelet activation during treatment with a glycoprotein IIb/IIIa antagonistDietmar Seiffert, Beth E Thomas, Jodi D Bradley, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 31, 2016
Inhibition of Factor XIa Reduces the Frequency of Cerebral Microembolic Signals Derived from Carotid Arterial Thrombosis in RabbitsXinkang Wang, Stan Kurowski, Weizhen Wu, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Biochemical and Biophysical Research Communications|December 3, 2002
Mutations at the P1' position of Notch1 decrease intracellular domain stability rather than cleavage by gamma-secretaseYuval Blat, Jere E Meredith, Qian Wang, et al.
European Journal of Pharmacology|April 11, 2015
Platelet transfusion reverses bleeding evoked by triple anti-platelet therapy including vorapaxar, a novel platelet thrombin receptor antagonistTian-Quan Cai, L Alexandra Wickham, Gary Sitko, et al.
Thrombosis and Haemostasis|March 8, 2003
CD32-dependent platelet activation by a drug-dependent antibody to glycoprotein IIb/IIIa antagonistsDonna L Pedicord, Ira Dicker, Karyn O'Neil, et al.
Thrombosis and Haemostasis|March 28, 2002
Plasminogen has a broad extrahepatic distributionLu Zhang, Dietmar Seiffert, Bruce J Fowler, et al.
The Journal of Biological Chemistry|January 5, 2002
Identification and characterization of presenilin-independent Notch signalingBridget E Berechid, Magali Kitzmann, Daniel R Foltz, et al.
European Journal of Heart Failure|June 7, 2019
Rationale and design for the development of a novel nitroxyl donor in patients with acute heart failureG Michael Felker, Maria Borentain, John G Cleland, et al.
Pharmacology Research & Perspectives|March 16, 2016
Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic targetWendy Ankrom, Harold B Wood, Jiayi Xu, et al.
Frontiers in Molecular Biosciences|June 26, 2023
Identification and validation of G protein-coupled receptors modulating flow-dependent signaling pathways in vascular endothelial cellsDike Qiu, Ke Xu, Namjin Chung, et al.
Platelets|July 10, 2003
Effects of the glycoprotein IIb/IIIa antagonist Roxifiban on P-selectin expression, fibrinogen binding, and microaggregate formation in a phase I dose-finding study: no evidence for platelet activation during treatment with a glycoprotein IIb/IIIa antagonistDietmar Seiffert, Beth E Thomas, Jodi D Bradley, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 31, 2016
Inhibition of Factor XIa Reduces the Frequency of Cerebral Microembolic Signals Derived from Carotid Arterial Thrombosis in RabbitsXinkang Wang, Stan Kurowski, Weizhen Wu, et al.
Pageof 5